Graham C. Parry

6.0k citations

75 papers · 5.0k indexed · h-index 36

Molecular Biology top 5%
Immunology top 2%
Cancer Research top 1%
Hematology top 0.5%
Oncology top 5%

Co-authors: Nigel Mackman Ronald R. Cobb Andrew P. Mazar Katherine A. Felts Paul Oeth Jonathan Erlich David E. Shaw Teresa Martin
Topics: Blood Coagulation and Thrombosis Mechanisms (20 papers)Protease and Inhibitor Mechanisms (20 papers)Cell Adhesion Molecules Research (16 papers)
Cited by: Immunology and Allergy Hematology Cancer Research
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States United Kingdom Austria

In The Last Decade

Graham C. Parry

75 papers receiving 4.9k citations

Peers

Countries citing papers authored by Graham C. Parry

Since Specialization

Citations

This map shows the geographic impact of Graham C. Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham C. Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham C. Parry more than expected).

Fields of papers citing papers by Graham C. Parry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham C. Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham C. Parry. The network helps show where Graham C. Parry may publish in the future.

Co-authorship network of co-authors of Graham C. Parry

This figure shows the co-authorship network connecting the top 25 collaborators of Graham C. Parry. A scholar is included among the top collaborators of Graham C. Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham C. Parry. Graham C. Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ELA026, a Monoclonal Antibody Targeting Signal Regulatory Protein-α/β1/γ, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naïve Malignancy-Associated Hemophagocytic Lymphohistiocytosis 2024 ·Blood ·Abhishek Maiti,Naval Daver,W. Thomas Johnson,Gaurav Goyal,Catherine M. Broome,Satyen H. Gohil,Jan van Laar,Javier López Jiménez,David McCall,(unknown),Benjamin Kim,Sandip Panicker,Gary Patou,Stephen J. Moore,Brian Mangal,(unknown),Graham C. Parry,(unknown),Carl E. Allen,Swaminathan P. Iyer	1
2	SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb 2023 ·Blood Advances ·Vaishnavi Rajagopal,Nina C. Leksa,Ronald D. Gorham,(unknown),(unknown),Kevin E. Knockenhauer,(unknown),Tony Byun,(unknown),Stephen J. Moore,Sandip Panicker,Graham C. Parry,Michael Storek	5
3	PB1311 Prophylactic Efficacy of VGA039, An Anti-Protein S Monoclonal Antibody, In A Novel Non-Human Primate Model of Acquired Von Willebrand Disease 2023 ·Research and Practice in Thrombosis and Haemostasis ·Ian Huck,Lilley Leong,Tony Byun,Beom Joon Kim,Aishan He,(unknown),Young June Choe,Christopher Horvath,Stephen J. Moore,Sandip Panicker,Graham C. Parry	3
4	Anti-C1s humanized monoclonal antibody SAR445088: A classical pathway complement inhibitor specific for the active form of C1s 2023 ·Clinical Immunology ·(unknown),(unknown),Sami Hussain,(unknown),Kate Markham,Tony Byun,Sandip Panicker,Graham C. Parry,Michael Storek	8
5	Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid 2019 ·Journal of Investigative Dermatology ·(unknown),(unknown),Ulla Derhaschnig,Christian Schoergenhofer,Christa Firbas,Graham C. Parry,Sandip Panicker,James C. Gilbert,Georg Stingl,Bernd Jilma,Peter Maximilian Heil	26
6	Inhibition of Tumor Cell Migration by LD22-4, an N-Terminal Fragment of 24-kDa FGF2, Is Mediated by Neuropilin 1 2013 ·Cancer Research ·Ling Zhang,Graham C. Parry,Eugene G. Levin	15
7	A monoclonal antibody targeting the human urokinase plasminogen activator receptor (uPAR) combined with bevacizumab inhibits the growth of colon cancer metastases in the liver: Differential effects mediated by tumor burden. 2007 ·Molecular Cancer Therapeutics ·George Van Buren,Michael J. Gray,Nikolaos A. Dallas,Ling Xia,Jose Juarez,Graham C. Parry,Fernando Doñate,Andrew P. Mazar,Lee M. Ellis	2
8	Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met– and Insulin-like Growth Factor-I Receptor–Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice 2005 ·Cancer Research ·Todd W. Bauer,Wenbiao Liu,Fan Fan,E. Ramsay Camp,Anthony Yang,Ray Somcio,Corazon D. Bucana,Jennifer Callahan,Graham C. Parry,Douglas B. Evans,Douglas D. Boyd,Andrew P. Mazar,Lee M. Ellis	120
9	In vitro and in vivo characterization of a monoclonal antibody, ATN-658, targeting the uPA system 2005 ·Cancer Research ·Jennifer Callahan,(unknown),Todd W. Bauer,Lee M. Ellis,Andrew P. Mazar,Graham C. Parry	2
10	Insulinlike Growth Factor-I???Mediated Migration and Invasion of Human Colon Carcinoma Cells Requires Activation of c-Met and Urokinase Plasminogen Activator Receptor 2005 ·Annals of Surgery ·Todd W. Bauer,Fan Fan,Wenbiao Liu,(unknown),Nila U. Parikh,Graham C. Parry,Jennifer Callahan,Andrew P. Mazar,Gary E. Gallick,Lee M. Ellis	54
11	Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1–143) 2005 ·Acta Crystallographica Section D Biological Crystallography ·Mingdong Huang,Andrew P. Mazar,Graham C. Parry,Abd Al‐Roof Higazi,Alice A. Kuo,Douglas B. Cines	17
12	Optimization of Crystals of an Inhibitory Antibody of Urokinase Plasminogen Activator Receptor (uPAR) with Hydrogen Peroxide and Low Protein Concentration 2005 ·Protein and Peptide Letters ·Yongdong Li,Xiaoli Shi,Graham C. Parry,Liqing Chen,Jennifer Callahan,Andrew P. Mazar,Mingdong Huang	1
13	Single-Chain Urokinase Alone or Complexed to Its Receptor in Tetracycline-induced Pleuritis in Rabbits 2002 ·American Journal of Respiratory and Critical Care Medicine ·Steven Idell,Andrew P. Mazar,Douglas B. Cines,Alice A. Kuo,Graham C. Parry,Susan L. Gawlak,Jose Juarez,(unknown),Ali Azghani,(unknown),Jerry McLarty,Edmund J. Miller	36
14	Inhibition of Cell Migration and Angiogenesis by the Amino-terminal Fragment of 24kD Basic Fibroblast Growth Factor 2002 ·Journal of Biological Chemistry ·(unknown),Fernando Doñate,Graham C. Parry,Xiaojun Guan,Pamela Maher,Eugene G. Levin	19
15	Low levels of tissue factor are compatible with development and hemostasis in mice. 1998 ·Journal of Clinical Investigation ·Graham C. Parry,Jonathan Erlich,Peter Carmeliet,Thomas Luther,Nigel Mackman	172
16	Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1 1997 ·European Journal of Immunology ·Teresa Martin,Pina M. Cardarelli,Graham C. Parry,Katherine A. Felts,Ronald R. Cobb	281
17	Proteasome inhibitors block VCAM‐1 and ICAM‐1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor‐ϰB 1996 ·European Journal of Immunology ·Ronald R. Cobb,Katherine A. Felts,Graham C. Parry,Nigel Mackman	41
18	Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial Cells 1996 ·Journal of Biological Chemistry ·Véronique Ollivier,Graham C. Parry,Ronald R. Cobb,Dominique de Prost,Nigel Mackman	309
19	Thrombin‐induced proliferation and expression of platelet‐derived growth factor‐A chain gene in human vascular smooth muscle cells 1992 ·FEBS Letters ·Chryso Kanthou,Graham C. Parry,Errol S. Wijelath,Vijay V. Kakkar,Catherine Demoliou-Mason	67
20	A prospective study of human papillomavirus infection of the cervix 1990 ·Cytopathology ·Micheline Byrne,Graham C. Parry,(unknown),David Taylor‐Robinson,A. D. B. Malcolm,D. V. Coleman	4

About Graham C. Parry

Graham C. Parry is a scholar working on Hematology, Immunology and Allergy and Cancer Research, having authored 75 papers that have together received 5.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Protease and Inhibitor Mechanisms (20 papers) and Cell Adhesion Molecules Research (16 papers). The work is most often cited by research in Immunology and Allergy (771 citations), Hematology (1.2k citations) and Cancer Research (1.4k citations). Graham C. Parry has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Nigel Mackman, Ronald R. Cobb, Andrew P. Mazar, Katherine A. Felts, Paul Oeth, Jonathan Erlich, David E. Shaw, Teresa Martin, Dominique de Prost and Véronique Ollivier. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact